Biotech Stocks on Fire: Moderna's Surge Sparks Interest in Five Top Picks

Moderna's stock price has skyrocketed by 177% in recent times, and investors are eager to know what comes next. MarketBeat's stock screener tool has identified five biotech stocks worth watching: Moderna (MRNA), AbbVie (ABBV), Gilead Sciences (GILD), Amgen (AMGN), and Danaher (DHR). These companies have experienced high trading volumes in the last few days, indicating significant investor interest.

Moderna is a biotechnology company that discovers, develops, and commercializes messenger RNA therapeutics and vaccines. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines. AbbVie offers a range of pharmaceuticals, including Humira, Skyrizi, Rinvoq, Imbruvica, Epkinly, Elahere, and Venclexta/Venclyxto.

Gilead Sciences discovers, develops, and commercializes medicines in areas of unmet medical need. Its products include Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, Sunlenca, Atripla, Veklury, Epclusa, Harvoni, Vemlidy, and Viread. Amgen discovers, develops, manufactures, and delivers human therapeutics worldwide.

Danaher designs, manufactures, and markets professional, medical, industrial, and commercial products and services. Its Biotechnology segment offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics.